Boston Institute of Biotechnology — 23 certified H-1B filings (FY2017–FY2026)
- 1
- Filings · FY2025
- $90k
- Median base · FY2025
- Chemist
- Top role · 2 all-time
- MA
- Top state · 21 all-time
Boston Institute of Biotechnology filed 1 certified H-1B LCAs in FY2025 (down 67% from the year before), with a median base salary of $90k and the middle 50% of offers between $90k and $90k. That is 13% below the market median for the same job titles. Across all years it has 23 certified filings since FY2017, most often for Chemist in Massachusetts.
How much does Boston Institute of Biotechnology pay H-1B workers?
Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $90k median in FY2025. Base pay only — hover a year for its figures.
How has Boston Institute of Biotechnology's H-1B hiring changed by year?
1 certified filings in FY2017 → 1 in FY2026. The change column is each year against the one before.
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2026 | 1 | 0% | $71k |
| FY2025 | 1 | −67% | $90k |
| FY2024 | 3 | −25% | $80k |
| FY2023 | 4 | +300% | $60k |
| FY2022 | 1 | −50% | $73k |
| FY2021 | 2 | −33% | $54k |
| FY2020 | 3 | −40% | $68k |
| FY2019 | 5 | +150% | $70k |
| FY2018 | 2 | +100% | $45k |
| FY2017 | 1 | — | $60k |
Which wage levels does Boston Institute of Biotechnology file?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 9% of Boston Institute of Biotechnology's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.
Share of 23 filings with a wage level · all years
- Level I65.2%15
- Level II26.1%6
- Level III8.7%2
What jobs does Boston Institute of Biotechnology sponsor for H-1B?
The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.
| Job title | Filings | Median base |
|---|---|---|
| Chemist | 2 | $70k |
| Research Associate I | 2 | $45k |
| Business Growth Specialist | 2 | $54k |
| Associate Scientist I | 2 | $45k |
| Scientist I | 2 | $68k |
| Scientist 1 | 1 | $80k |
| Scientist II | 1 | $99k |
| Senior Scientist I | 1 | $100k |
| Sr. Scientist I | 1 | $105k |
| Strategic Marketing Analyst | 1 | $60k |
Where does Boston Institute of Biotechnology hire H-1B workers?
Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.
| State | Filings | Median base |
|---|---|---|
| MA | 21 | $70k |
| CA | 2 | $60k |
What has Boston Institute of Biotechnology filed recently?
Every certified LCA on record for Boston Institute of Biotechnology: job title, worksite, prevailing-wage level and the offered base salary.
| FY | Job title | Base salary |
|---|---|---|
| 2026 | Associate Scientist | $71,000 |
| 2025 | Business Intelligence Analysts (00083402) | $90,000 |
| 2024 | Scientist 1 | $80,000 |
| 2024 | Research Associate I | $50,000 |
| 2024 | Senior Scientist I | $100,000 |
| 2023 | Sr. Scientist I | $105,000 |
| 2023 | Associate Scientist I | $60,000 |
| 2023 | Business Intelligence Analyst [00043299] | $75,029 |
| 2023 | Research Associate I | $45,000 |
| 2022 | Business Growth Specialist | $72,800 |
| 2021 | Business Growth Specialist | $54,080 |
| 2021 | Strategic Marketing Analyst | $59,987 |
| 2020 | Scientist I | $68,000 |
| 2020 | Clinical Technologist | $42,500 |
| 2020 | Scientist II | $99,000 |
| 2019 | Business Intelligence Analyst | $62,500 |
| 2019 | Research Associate II | $42,500 |
| 2019 | Chemist | $70,000 |
| 2019 | Chemist | $70,000 |
| 2019 | Microbiol and Mammalian Cell Line Development Scientist | $70,000 |
| 2018 | Scientist I | $70,000 |
| 2018 | Associate Scientist I | $45,000 |
| 2017 | Associate Scientist II | $60,000 |
Common questions about Boston Institute of Biotechnology's H-1B filings
- How much does Boston Institute of Biotechnology pay H-1B workers?
- Boston Institute of Biotechnology's median certified H-1B base salary is $90k (FY2025), from 1 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Boston Institute of Biotechnology sponsor?
- Boston Institute of Biotechnology has 23 certified H-1B Labor Condition Applications on record (FY2017–FY2026).
- What jobs does Boston Institute of Biotechnology sponsor for H-1B?
- Boston Institute of Biotechnology's most-sponsored H-1B roles include Chemist, Research Associate I, Business Growth Specialist, Associate Scientist I.
- Where does Boston Institute of Biotechnology hire H-1B workers?
- Boston Institute of Biotechnology's top H-1B worksite states are MA, CA.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2017–FY2026). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →